TR200601782T2 - 2'-Deoksi-L-Nükleositlerin sentezi. - Google Patents

2'-Deoksi-L-Nükleositlerin sentezi.

Info

Publication number
TR200601782T2
TR200601782T2 TR2006/01782T TR200601782T TR200601782T2 TR 200601782 T2 TR200601782 T2 TR 200601782T2 TR 2006/01782 T TR2006/01782 T TR 2006/01782T TR 200601782 T TR200601782 T TR 200601782T TR 200601782 T2 TR200601782 T2 TR 200601782T2
Authority
TR
Turkey
Prior art keywords
nucleosides
deoxy
synthesis
chr
nhr
Prior art date
Application number
TR2006/01782T
Other languages
English (en)
Inventor
A. Watanabe Kyoichi
Baeg Choi Woo
Original Assignee
Pharmasset Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmasset Ltd. filed Critical Pharmasset Ltd.
Publication of TR200601782T2 publication Critical patent/TR200601782T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C07H1/06—Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Mevcut buluş; (A) yapısına sahip bileşiklerin hazırlanması için prosesler sağlamakta olup, söz konusu yapı içerisindeki X ve Y; aynı veya farklıdır ve H, OH, OR, SH, SR, NH2, NHR' veya NR'R''' 'dür; Z; H, F, Cl,Br, I, CN veya NH² 'dir. R; hidrojen, halojen, C1-C6 düşük alkil, aralkil, NO2, NH2, NHR', NR'R'', OH, OR, SH, SR, CN, CONH2, CSNH2, CO2H,CO2R', CH2CO2H, CH2CO2R', CH=CHR, CH2CH=CHR veya C=CR 'dir. R' ve R'', aynı veya farklıdır, ve C1-C6 düşük alkildir. R13, hidrojen, alkil, asil, fosfat (monofosfat, difosfat, trifosfat, veya stabilize fosfat) veya silildir.
TR2006/01782T 1999-11-12 2000-11-13 2'-Deoksi-L-Nükleositlerin sentezi. TR200601782T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16508799P 1999-11-12 1999-11-12

Publications (1)

Publication Number Publication Date
TR200601782T2 true TR200601782T2 (tr) 2006-09-21

Family

ID=22597367

Family Applications (3)

Application Number Title Priority Date Filing Date
TR2006/01784T TR200601784T2 (tr) 1999-11-12 2000-11-13 2'-deoksi-L-nükleositlerin sentezi
TR2006/01782T TR200601782T2 (tr) 1999-11-12 2000-11-13 2'-Deoksi-L-Nükleositlerin sentezi.
TR2006/01783T TR200601783T2 (tr) 1999-11-12 2000-11-13 2'-Deoksi-L-nükleositlerin sentezi

Family Applications Before (1)

Application Number Title Priority Date Filing Date
TR2006/01784T TR200601784T2 (tr) 1999-11-12 2000-11-13 2'-deoksi-L-nükleositlerin sentezi

Family Applications After (1)

Application Number Title Priority Date Filing Date
TR2006/01783T TR200601783T2 (tr) 1999-11-12 2000-11-13 2'-Deoksi-L-nükleositlerin sentezi

Country Status (12)

Country Link
US (1) US20050090660A1 (tr)
EP (1) EP1232166A2 (tr)
JP (1) JP2003513984A (tr)
KR (1) KR100789162B1 (tr)
CN (4) CN1423654A (tr)
AU (3) AU784374C (tr)
BR (1) BR0015530A (tr)
CA (1) CA2391279A1 (tr)
IL (2) IL149592A0 (tr)
MX (1) MXPA02004779A (tr)
TR (3) TR200601784T2 (tr)
WO (1) WO2001034618A2 (tr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6822089B1 (en) 2000-03-29 2004-11-23 Isis Pharmaceuticals, Inc. Preparation of deoxynucleosides
KR101195019B1 (ko) * 2000-10-18 2012-10-29 파마셋 인코포레이티드 바이러스 감염 및 비정상적인 세포 증식의 치료를 위한 변형된 뉴클레오시드
DE10216426A1 (de) * 2002-04-12 2003-10-23 Boehringer Ingelheim Pharma Verfahren zur Herstellung von beta-L-2'Deoxy-Thymidin
TWI244393B (en) * 2002-08-06 2005-12-01 Idenix Pharmaceuticals Inc Crystalline and amorphous forms of beta-L-2'-deoxythymidine
PT1633766T (pt) * 2003-05-30 2019-06-04 Gilead Pharmasset Llc Análogos de nucleósido fluorado modificado
WO2005026186A1 (de) * 2003-09-12 2005-03-24 Max-Delbrück-Centrum für Molekulare Medizin Β-l-nucleoside und ihre verwendung als pharmazeutische mittel zur behandlung viraler erkrankungen
CN101023094B (zh) * 2004-07-21 2011-05-18 法莫赛特股份有限公司 烷基取代的2-脱氧-2-氟代-d-呋喃核糖基嘧啶和嘌呤及其衍生物的制备
WO2006031725A2 (en) * 2004-09-14 2006-03-23 Pharmasset, Inc. Preparation of 2'­fluoro-2'- alkyl- substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivatives
US7759342B2 (en) 2005-01-13 2010-07-20 Signal Pharmaceuticals, Llc Methods of treatment and prevention using haloaryl substituted aminopurines
US7723340B2 (en) 2005-01-13 2010-05-25 Signal Pharmaceuticals, Llc Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith
US7521446B2 (en) 2005-01-13 2009-04-21 Signal Pharmaceuticals, Llc Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith
JP4995811B2 (ja) * 2005-04-29 2012-08-08 クック・バイオテック・インコーポレーテッド 瘻治療用容積式移植片並びに関連の方法及びシステム
US7964580B2 (en) 2007-03-30 2011-06-21 Pharmasset, Inc. Nucleoside phosphoramidate prodrugs
US8173621B2 (en) * 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
AU2009274127A1 (en) * 2008-07-21 2010-01-28 Arstasis, Inc. Devices, methods, and kits for forming tracts in tissue
CA2743796C (en) 2008-11-17 2016-10-25 Anadys Pharmaceuticals, Inc. Method of preparing deoxyribofuranose compounds
EP2376514A2 (en) 2008-12-23 2011-10-19 Pharmasset, Inc. Nucleoside analogs
TW201031675A (en) 2008-12-23 2010-09-01 Pharmasset Inc Synthesis of purine nucleosides
EP2376088B1 (en) 2008-12-23 2017-02-22 Gilead Pharmasset LLC 6-O-Substituted-2-amino-purine nucleoside phosphoramidates
TWI598358B (zh) 2009-05-20 2017-09-11 基利法瑪席特有限責任公司 核苷磷醯胺
US8618076B2 (en) 2009-05-20 2013-12-31 Gilead Pharmasset Llc Nucleoside phosphoramidates
CN101555266B (zh) * 2009-05-25 2011-11-30 上海医药工业研究院 一种替比夫定的制备方法
US8563530B2 (en) 2010-03-31 2013-10-22 Gilead Pharmassel LLC Purine nucleoside phosphoramidate
UY33311A (es) 2010-03-31 2011-10-31 Pharmasset Inc Fosforamidatos de nucleosidos
KR101198302B1 (ko) 2010-11-02 2012-11-07 서울대학교산학협력단 Ｃｄｋ를 저해하는 피롤로피리미디논 카복사미드 유도체 또는 이의 약학적으로 허용가능한 염, 이를 유효성분으로 함유하는 간세포암의 예방 또는 치료용 약학적 조성물
US8841275B2 (en) 2010-11-30 2014-09-23 Gilead Pharmasset Llc 2′-spiro-nucleosides and derivatives thereof useful for treating hepatitis C virus and dengue virus infections
US8889159B2 (en) 2011-11-29 2014-11-18 Gilead Pharmasset Llc Compositions and methods for treating hepatitis C virus
US9868733B2 (en) 2012-08-22 2018-01-16 Merck Sharp & Dohme Corp. Azabenzimidazole tetrahydrofuran derivatives
MX2016002185A (es) 2013-08-27 2016-06-06 Gilead Pharmasset Llc Formulacion combinada de dos compuestos antivirales.
CN112533607A (zh) * 2018-05-25 2021-03-19 普利缪尼治疗学股份有限公司 Tlr7激动剂
CN109369758B (zh) * 2018-11-02 2021-04-13 哈尔滨商业大学 5′-(6-氯烟酰酯)-3′-脱氧腺苷的合成方法及其应用
CN109020974B (zh) * 2018-11-02 2021-01-05 哈尔滨商业大学 5′-噻吩甲酰酯-3′-脱氧腺苷的合成方法及其应用
CN109111445B (zh) * 2018-11-02 2020-12-18 哈尔滨商业大学 5’-呋喃甲酰酯-3’-脱氧腺苷的合成方法及应用
CN115427063A (zh) 2019-11-26 2022-12-02 普利缪尼治疗学股份有限公司 Tlr7激动剂

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) * 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US5047407A (en) * 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
US5041449A (en) * 1988-04-11 1991-08-20 Iaf Biochem International, Inc. 4-(nucleoside base)-substituted-1,3-dioxolanes useful for treatment of retroviral infections
US5200514A (en) * 1990-01-19 1993-04-06 University Of Georgia Research Foundation, Inc. Synthesis of 2'-deoxypyrimidine nucleosides
US5204466A (en) * 1990-02-01 1993-04-20 Emory University Method and compositions for the synthesis of bch-189 and related compounds
IT1246983B (it) * 1990-11-13 1994-12-12 Consiglio Nazionale Ricerche L-2'-desossiuridine e composizioni farmaceutiche che le contengono.
FR2709754B1 (fr) * 1993-09-10 1995-12-01 Centre Nat Rech Scient Composés 2' ou 3'-déoxy- et 2', 3'-didéoxy-beta-L-pentofuranonucléosides, procédé de préparation et application thérapeutique, notamment anti-virale.
US5559101A (en) * 1994-10-24 1996-09-24 Genencor International, Inc. L-ribofuranosyl nucleosides
US6025335A (en) * 1995-09-21 2000-02-15 Lipitek International, Inc. L-Nucleoside Dimer Compounds and therapeutic uses
CA2340156C (en) * 1998-08-10 2007-10-23 Novirio Pharmaceuticals Limited .beta.-l-2'-deoxy-nucleosides for the treatment of hepatitis b
US6444652B1 (en) * 1998-08-10 2002-09-03 Novirio Pharmaceuticals Limited β-L-2'-deoxy-nucleosides for the treatment of hepatitis B
US6407077B1 (en) * 1998-11-05 2002-06-18 Emory University β-L nucleosides for the treatment of HIV infection

Also Published As

Publication number Publication date
AU2005204267A1 (en) 2005-09-22
AU2005204266B2 (en) 2008-11-06
WO2001034618A2 (en) 2001-05-17
CA2391279A1 (en) 2001-05-17
TR200601783T2 (tr) 2007-01-22
AU2005204266A1 (en) 2005-09-22
CN1423654A (zh) 2003-06-11
IL149592A (en) 2008-11-26
AU784374C (en) 2007-06-28
AU1485801A (en) 2001-06-06
KR100789162B1 (ko) 2007-12-28
AU784374B2 (en) 2006-03-23
CN1919859A (zh) 2007-02-28
TR200601784T2 (tr) 2007-01-22
CN1919860A (zh) 2007-02-28
WO2001034618A3 (en) 2002-01-03
CN1919858A (zh) 2007-02-28
BR0015530A (pt) 2003-02-18
IL149592A0 (en) 2002-11-10
JP2003513984A (ja) 2003-04-15
EP1232166A2 (en) 2002-08-21
US20050090660A1 (en) 2005-04-28
KR20030025220A (ko) 2003-03-28
AU2005204267B2 (en) 2008-10-23
MXPA02004779A (es) 2004-07-01

Similar Documents

Publication Publication Date Title
TR200601782T2 (tr) 2'-Deoksi-L-Nükleositlerin sentezi.
DE69831499D1 (de) Inhibitoren des nukleosid-metabolismus
ES2155219T3 (es) Compuestos nucleotidos de fosfonato.
NZ335013A (en) Compositions comprising cytosine derivatives for the treatment of cancer
HUP0002893A2 (hu) Szubsztituált kinazolinszármazékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények
HUP0001993A2 (hu) Fungicid hatású (trifluor-metil-alkil)-amino-triazol 0[1,5-a]pirimidin-származékok, előállításuk és alkalmazásuk
DE69823648D1 (de) 1-phenyl-4-benzylpiperazine: spezifische liganden für den dopamin rezeptor (d4)
MY109846A (en) Dual inhibitors of no synthase and cyclooxygenase, process for their preparation and therapeutical compositions containing them
HUP0300909A2 (hu) NHE-3 inhibitor hatású 2-guanidino-4-aril-kinazolin-származékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
HUP0004106A2 (hu) Új adenozinszármazékok, eljárás előállításukra, azokat hatóanyagként tartalmazó gyógyszerkészítmények, valamint ilyen hatóanyagok alkalmazása gyógyszerkészítmények előállítására
CA2502109A1 (en) 4'-c-substituted-2-haloadenosine derivative
MX9605809A (es) Nuevos esteres lipidicos de monofosfatos nucleosidos y su uso como medicamentos inmunosupresores.
PT1442024E (pt) Derivados aminobenzamida como inibidores da glicogénio sintase quinase 3$g(b)
HUP0401987A2 (hu) A triazolil-imidazopiridin és a triazolilpurin vegyületek adenozin-a2A-receptorligandumként használható származékai és gyógyszerként történő alkalmazásuk
HUP0004071A2 (hu) Prosztaglandin-származékokat tartalmazó gyógyszerkészítmények
HUP0003954A2 (hu) Eljárás és közbenső termékek pirrolo [2,3-d] pirimidin-származékok előállítására
HUP0203288A2 (hu) Foszfodiészteráz VII inhibitor hatású pirrolszármazékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
HUP0203422A2 (hu) Foszfodiészteráz VII inhibitor hatású imidazolszármazékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
HUP0202414A2 (hu) Új eljárás perindopril és analógjai, és ezek sói előállítására
HUP0101832A2 (hu) PDE V gátló hatású, kondenzált tienopirimidinszármazékok és az ezeket tartalmazó gyógyszerkészítmények
HUP0003155A2 (hu) Eljárás COX-2 inhibitorként alkalmazható 2-aril-3-aril-5-halogénpiridin-származékok előállítására
Veres et al. 5-Substituted-2, 2′-anhydrouridines, potent inhibitors of uridine phosphorylase
AR003456A1 (es) Un compuesto analogo de distamicina y sus sales, procedimiento para su preparacion, composicion farmaceutica que lo contiene y usos del mismo.
HUP0402033A2 (hu) 2-Amino-4-piridil-metil-tiazolin-származékok alkalmazása az indukálható NO-szintetáz inhibitoraként, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
NO933726L (no) Inhibitorer for kynureninase